Browne Jacobson appoints Kevin Moore as partner

Browne Jacobson has appointed Kevin Moore, an expert in life sciences, enhancing its All-Island strategy for growth
Browne Jacobson has announced the appointment of Kevin Moore as Commercial Partner, a significant development in their ambition to create a comprehensive legal framework for life sciences across the island of Ireland. Kevin brings over 15 years of experience in advising businesses at every stage of the life sciences lifecycle, from initial innovation and investment through to commercialisation, market entry, and strategic exits. He has a strong background in manufacturing and supply arrangements that support life science products in the market.
Most recently, Moore founded DeNovo Legal, a specialist firm that has served as a trusted advisor to burgeoning and scaling companies in Galway and the broader Irish life sciences cluster. An alumnus of the University of Galway BioInnovate Fellowship Programme, Moore has developed strong connections within the health technology innovation landscape, comparable to prestigious programmes like Stanford Biodesign.
At Browne Jacobson, Kevin will collaborate with Dublin-based Corporate Partners Will Darmody and Gavin Bluett, alongside Chiara Quondamatteo, a Corporate Associate focused on life sciences. This integrated team will be equipped to provide comprehensive legal advice covering everything from foundational commercial contracts to significant cross-border transactions and regulatory issues.
The timing of Moore's appointment aligns with Browne Jacobson’s ongoing expansion into Belfast, following its partnership with Davidson McDonnell. This strategic move allows the firm to establish a presence that encompasses Galway, Dublin, and Belfast, thus creating a robust legal platform across the entire island of Ireland.
Kevin Moore expressed enthusiasm about joining the firm, stating “Browne Jacobson has an excellent reputation in health and life sciences across the UK and Ireland, together with strong network connections in the United States and the Middle East. I believe my experience of working with a broad spectrum of life sciences companies in Ireland will support the firm’s growing footprint here.” He added, “This is an exciting time to be joining Browne Jacobson. The firm's reach, its investment in life sciences and the quality of the team will be of real value to companies here.”
Browne Jacobson sees Galway as a global epicentre for life sciences and vascular technology, with Kevin Moore standing at the forefront of this thriving ecosystem. Specialising in commercial agreements, intellectual property issues, research collaborations, and investment transactions for MedTech and diagnostics businesses, he aims to enhance how Irish life sciences companies engage with legal services as they expand internationally.
Gerard Hanratty, Partner and Head of Health and Life Sciences at Browne Jacobson, remarked, “Galway is a world-class life sciences cluster and Kevin sits right at the heart of it. His expertise, network and track record make him an outstanding addition to our team, and his appointment takes our life sciences capability to a new level.” He added, “We are highly ambitious about growing our work in life sciences, a sector packed with innovators working at the very cutting edge of improving the health and wellbeing of people everywhere.”
Gavin Bluett also commented on the significance of the appointment, calling it “a statement of ambition” as Browne Jacobson continues to build a differentiated presence in Ireland. His view is supported by the recent hiring of Chris Holder from Bristows, emphasising the firm's commitment to developing a market-leading life sciences practice across the UK and Ireland. Together, Moore and Holder's appointments signal a sustained investment in a sector filled with innovation and potential, aligning with Browne Jacobson's mission to address pressing societal challenges through expert legal support.






.jpg&w=3840&q=60)







.jpg&w=3840&q=60)